Moreover, EZH2 is able to directly interact with β-catenin and ERα in a PRC2-independent manner to activate cyclin D1 and c-Myc expression upon estrogen stimulation to induce the proliferation of breast cancer cells (Figure 5D) [256]. The gene discussed is ESR1; the disease is breast carcinoma.